DrugRepV_0620 | Levopropoxyphene | Respiratory-Tract-agents | Cough and associated respiratory tract disorders | Lassa virus | GP derived Pseudovirus | NA | Luciferase reporter assay | Decrease (79 %) | Withdrawn | 23577127 |
DrugRepV_0659 | Levopropoxyphene | Respiratory-Tract-agents | Cough and associated respiratory tract disorders | Marburg virus | GP derived Pseudovirus | NA | Luciferase reporter assay | Decrease (89 %) | Withdrawn | 23577127 |
DrugRepV_0683 | Levopropoxyphene | Respiratory-Tract-agents | Cough and associated respiratory tract disorders | Ebola virus | GP derived Pseudovirus | NA | Luciferase reporter assay | Decrease (98 %) | Withdrawn | 23577127 |
DrugRepV_1161 | Pemirolast Potassium | Respiratory-Tract-agents | Eye itching caused by allergies such as hay fever, and allergic conjunctivitis | Zika virus | MEX_I_7 | NA | Fluorescence-based assay | Decrease (47.52 %) | Approved | 27476412 |
DrugRepV_2024 | Oxeladin | Respiratory-Tract-agents | Cough | Ebola virus | Zaire strain-pEBOV | NA | Firefly luciferase assay | Decrease (50 %) | Withdrawn | 26585243 |